Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genesis Medical Interventional was a medical device company based in Redwood City, California, that specialized in minimally invasive solutions for vascular diseases. The company's core technology was the F.A.S.T. (Facilitated Aspiration/Suction Thrombectomy) Funnel Catheter system, which provided embolic protection and thrombus removal during interventional procedures. This platform utilized a unique funnel-shaped occluder to harness the patient's own blood pressure for vascular occlusion, allowing for safer and more effective aspiration of debris. The F.A.S.T. system received FDA 510(k) clearance for peripheral use and was recognized with a Medical Design Excellence Award in 2005. In 2010, the company's assets were acquired by Micrus Endovascular, which was subsequently acquired by Johnson & Johnson.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genesis Medical Interventional.